Haroun-Izquierdo and colleagues produced adaptive single self-KIR+NKG2C+ NK cells, named ADAPT-NK cells, which have a higher proliferation rate compared to common adaptive NK cells, in both in vitro and in vivo AML tumor cell models [38]. This evidence concerns the gene KLRC2 and acute myeloid leukemia.